Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, and kills up to 30,000. It is a leading cause of health-care-associated ...

If hospitals want to prevent Clostridium difficile infections, it’s essential they adopt antimicrobial stewardship programs, according to updated guidance from five medical organizations. In 2014, the ...

Nearly half a million people in the United States suffer from an intestinal infection called Clostridium difficile each year. Approximately half of those individuals become sick enough to require ...

CAMBRIDGE, Mass. & HOBOKEN, N.J.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) and Nestlé Health Science today announced that VOWST™ (fecal microbiota spores, live-brpk) is now ...

SALT LAKE CITY – Over the past two decades there has been a sharp rise in the number and severity of infections caused by the bacteria Clostridium difficile often shortened to C. diff now the most ...

LPOXY is advancing SIDIPREV™ to a pivotal clinical trial to prevent C. difficile infections, which kill more Americans each year than all other CDC Urgent Threat infections combined. Founded in 2020 ...

The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research. The ...

C. diff is a horrible disease that can cause significant morbidity. It can and often does recur and kills around 30,000 Americans every year. We have made progress in prevention and treatment, but ...

The Consumer Reports ratings are based on data hospitals reported to the CDC between October 2014 and September 2015. The data is released periodically over the year. Consumer Reports also released C.

ACG Stool Transplants Stop 90% of C difficile Recurrences Fecal microbiota transplants, also known as stool transplants, succeeded in 91% of patients with recurrent C difficile infections who had ...